中心夜间血液透析与传统血液透析的系统评价
该系统评价检索多个数据库至2016年11月,纳入21项观察性研究,共1,165例中心夜间HD患者和15,865例传统HD患者。结果显示中心夜间HD与收缩压降低、血红蛋白升高和血磷降低相关,但缺乏随机试验证据。
要点
- 中心夜间HD与收缩压降低3.18 mmHg、血红蛋白升高0.53 g/dL、血磷降低0.97 mg/dL相关。
- 无随机对照试验,证据来自观察性研究,质量普遍差至中等。
- 无预设结局显示中心夜间HD更差,但因样本量小其他获益可能未被发现。
核心结论
- 与传统HD相比,中心夜间HD与多个临床相关结局的改善相关。
- 无预设结局显示中心夜间HD更差。
研究设计与样本
- 系统评价检索MEDLINE、Embase、EBMR、Web of Science和Scopus至2016年11月。
- 纳入21项准实验或观察性研究,共1,165例中心夜间HD患者和15,865例传统HD患者。
- 未找到随机对照试验。
主要发现
- 中心夜间HD与收缩压降低3.18(95%CI -5.58至-0.78)mmHg相关。
- 中心夜间HD与血红蛋白升高0.53(95%CI 0.11至0.94)g/dL相关。
- 中心夜间HD与血磷降低0.97(95%CI -1.48至-0.46)mg/dL相关。
- 结局报告异质性普遍较高。
临床怎么用
- 中心夜间HD可能改善血压、贫血和矿物质代谢,但证据级别有限。
- 临床决策需结合患者情况和中心条件,考虑观察性研究的局限性。
局限性
- 无随机对照试验评估中心夜间HD的临床效果。
- 观察性文献质量普遍差至中等,混杂结局是重要问题。
- 可能存在发表偏倚和结局报告偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Owing to its longer treatment duration-up to 8 hours per dialysis treatment-in-center thrice-weekly nocturnal hemodialysis (HD) is receiving greater attention. To better understand the evidence for in-center nocturnal HD, we sought to systematically review the literature to determine the effects of in-center nocturnal HD versus conventional HD on clinically relevant outcomes. STUDY DESIGN: We searched MEDLINE, Embase, Evidence-Based Medicine Reviews (EBMR), Web of Science, and Scopus from the earliest date in the database to November 2016. SETTING & POPULATION: Adults receiving in-center nocturnal HD compared with those receiving conventional HD. SELECTION CRITERIA FOR STUDIES: All quasi-experimental and observational studies were considered; randomized trials were sought but not found. PREDICTOR: Nocturnal vs conventional in-center HD. OUTCOMES: Indexes of blood pressure and left ventricular hypertrophy, markers of anemia, measures of bone mineral metabolism, nutrition, quality of life, sleep quality, episodes of intradialytic hypotension, hospitalization, and mortality. RESULTS: Of 2,086 identified citations, 21 met the inclusion criteria, comprising a total of 1,165 in-center nocturnal HD patients and 15,865 conventional HD patients. Although there was substantial heterogeneity in reporting of outcomes, we pooled data for measures of blood pressure, anemia, and mineral metabolism. Though heterogeneity was generally high, in-center nocturnal HD was associated with improved systolic blood pressure (-3.18 [95% CI, -5.58 to -0.78) mm Hg, increased hemoglobin levels (0.53 [95% CI, 0.11-0.94] g/dL), and lower serum phosphate levels (-0.97 [95% CI, -1.48 to -0.46] mg/dL). LIMITATIONS: No randomized trials have been conducted to address the clinical effects of in-center nocturnal HD. The quality of the observational literature contributing to the results of this review was generally poor to moderate. Confounded outcomes are a significant concern. Publication bias and outcome reporting bias remain possibilities. CONCLUSIONS: Relative to conventional HD, in-center nocturnal HD was associated with improvements in several clinically relevant outcomes. Other benefits may not have been detected due to small sample sizes of included studies; no prespecified outcome was worse with in-center nocturnal HD.
引用
- Wong B, Collister D, Muneer M, et al. In-Center Nocturnal Hemodialysis Versus Conventional Hemodialysis: A Systematic Review of the Evidence. Am J Kidney Dis. 2017. PMID: 28359656. doi:10.1053/j.ajkd.2017.01.047
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。